| Literature DB >> 34880632 |
Cong Su1, Ting Wu2, Bao Meng2, Chengcheng Yue2, Yating Sun2, Lingling He2, Tingting Bian2, Yanyan Liu3,4, Ying Huang5, Yanhu Lan4, Jiabin Li2,3,4,6.
Abstract
BACKGROUND: Klebsiella pneumoniae (K. pneumoniae) causes community-acquired and hospital-acquired pneumonia. The mortality rates of invasive infections caused by hypervirulent K. pneumoniae (HvKP) are extremely high. However, the microbiological characteristics and clinical manifestations of K. pneumoniae in AnHui province still remain unclear.Entities:
Keywords: Klebsiella pneumoniae; antimicrobial resistance; capsular types; virulence genes
Year: 2021 PMID: 34880632 PMCID: PMC8645949 DOI: 10.2147/IDR.S336451
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Primer Sequence About Virulence and Resistance Associated Genes
| Prime Name | Sequence | |
|---|---|---|
| Forward | ACTGGGCTACCTCTGCTTCA | |
| Reverse | CGCACCAGTAATTCCAACAG | |
| Forward | CTTTATGTGCAATAAGGATGTT | |
| Reverse | CCTCCTGGAGAGTAAGCATT | |
| K1 | Forward | GGTGCTCTTTACATCATTGC |
| Reverse | GCAATGGCCATTTGCGTTAG | |
| K2 | Forward | GGAGCCATTTGAATTCGGTG |
| Reverse | TCCCTAGCACTGGCTTAAGT | |
| K5 | Forward | GCCACCTCTAAGCATATAGC |
| Reverse | CGCACCAGTAATTCCAACAG | |
| K20 | Forward | CCGATTCGGTCAACTAGCTT |
| Reverse | GCACCTCTATGAACTTTCAG | |
| K54 | Forward | CATTAGCTCAGTGGTTGGCT |
| Reverse | GCTTGACAAACACCATAGCAG | |
| Forward | ATGTCACTGTATCGCCGTCT | |
| Reverse | TTTTCAGAGCCTTACTGCCC | |
| Forward | GGTTTGGCGATCTGGTTTTC | |
| Reverse | CGGAATGGCTCATCACGATC | |
| Forward | AAATTCCGGTCGGAGAGGTC | |
| Reverse | AATGCGCAGCACCAGGATAG | |
| Forward | GGAATAGAGTGGCTTAATTCTCC | |
| Reverse | GGTTTAATAAAACAACCACC | |
| Forward | GCGTGGTTAAGGATGAACAC | |
| Reverse | CATCAAGTTCAACCCAACCG | |
Figure 1Distribution percentage of 68 strains of HvKP.
Clinical and Microbiological Characteristics of HvKP Isolates
| Characteristics | NO.(%) of Isolates | ||
|---|---|---|---|
| HvKP (n=68) | Non-HvKP (n=47) | ||
| Male sex | 43 (63.2) | 35 (74.5) | 0.205 |
| Age (years) (mean ± SD) | 57.01 ± 19.00 | 57.26 ± 16.20 | 0.944 |
| K1 | 21/68 (30.9) | 2/47 (4.3) | 0.000 |
| K2 | 26/68 (38.2) | 9/47 (19.1) | 0.029 |
| K5 | 12/68 (17.6) | 4/47 (8.5) | 0.164 |
| K20 | 0/68 (0.0) | 2/47 (4.3) | 0.086 |
| K57 | 8/68 (11.8) | 1/47 (2.1) | 0.059 |
| Ceftazidime | 13/68 (19.1) | 12/47 (25.5) | 0.093 |
| Ceftriaxone | 14/68 (20.6) | 15/47 (32.0) | 0.028 |
| Cefepime | 13/68 (19.1) | 11/47 (23.4) | 0.030 |
| Cefotaxime | 14/68 (20.6) | 15/47 (32.0) | 0.028 |
| Piperacillin-tazobactam | 12/68 (17.6) | 9/47 (19.1) | 0.273 |
| Cefoperazone-sulbactam | 13/68 (19.1) | 10/47 (21.3) | 0.254 |
| Imipenem | 12/68 (17.6) | 10/47 (21.3) | 0.168 |
| Meropenem | 12/68 (17.6) | 10/47 (21.3) | 0.168 |
| Amikacin | 12/68 (17.6) | 6/47 (12.8) | 0.872 |
| Gentamicin | 13/68 (19.1) | 10/47 (21.3) | 0.254 |
| Ciprofloxacin | 15/68 (22.1) | 14/47 (29.8) | 0.082 |
| Levofloxacin | 14/68 (20.6) | 13/47 (27.7) | 0.088 |
| Aztreonam | 15/68 (22.1) | 14/47 (29.8) | 0.082 |
| Tigecycline | 0/68 (0) | - | - |
| Colistin | 0/68 (0) | - | - |
| Carbapenemase | 12/68 (17.6) | 11/47 (23.4) | 0.448 |
| Cancer | 7 (10.3) | 12 (25.5) | 0.031 |
| Liver abscess | 8 (11.8) | 1 (0.02) | 0.059 |
| Hypertension | 21 (44.7) | 15 (32.0) | 0.907 |
| Diabetes | 18 (26.5) | 8 (17.0) | 0.234 |
| Pulmonary disease | 19 (28.0) | 12 (25.5) | 0.775 |
| Invasive equipment | 33 (48.5) | 21 (44.7) | 0.684 |
Clinical and Microbiological Characteristics of Carbapenemase Producing HvKP Isolates
| Strain4 | Strain7 | Strain16 | Strain29 | Strain32 | Strain34 | Strain35 | Strain37 | Strain38 | Strain51 | Strain55 | Strain68 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gender | Male | Male | Male | Male | Female | Female | Male | Male | Male | Male | Female | Male |
| Age | 56 | 52 | 46 | 54 | 53 | 33 | 29 | 81 | 55 | 50 | 60 | 44 |
| String test | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | |
| + | + | + | + | + | + | + | + | + | + | + | + | |
| K14/K64 | K14/K64 | K14/K64 | K14/K64 | K14/K64 | K14/K64 | K14/K64 | K14/K64 | K14/K64 | K2 | No-K-type | K14/K64 | |
| MLST | ST11 | ST11 | ST11 | ST11 | ST11 | ST11 | ST11 | ST11 | ST11 | ST25 | ST11 | ST11 |
| KPC-2 | + | + | + | + | - | + | + | + | + | - | + | + |
| NDM-1 | - | + | + | + | + | - | + | + | + | + | + | + |
| VIM-1 | + | + | + | + | + | + | + | + | + | - | + | + |
| IMP-1 | - | - | - | - | - | - | - | - | - | - | - | - |
| OXA-48 | + | + | + | + | + | + | + | + | + | + | + | + |
| Specimen type | Sputum | Secretions | Sputum | Blood | Venous catheter | Sputum | Sputum | Sputum | Sputum | Sputum | Sputum | Puncture fluid |
| Infection type | Pneumonia | Pneumonia | Pneumonia | Pneumonia | Pneumonia | Pneumonia | Sepsis | Sepsis | Pneumonia | Pneumonia | Pneumonia | Abdominal infection |
| Clinical outcomes | Survived | Survived | Survived | Survived | Survived | Survived | Died | Died | Died | Survived | Survived | Survived |
Figure 2Pulsed field gel electrophoresis (PFGE) cluster analysis of 68 strains of HvKP from different sources. Four highly homologous isolates from carbapenemase producing HvKP have been marked with a black circle to the serial number left.